I spoke with Stasiek at EVS23 this past week, and he gave AutoblogGreen a rundown on his company's new ATEV 28 (All-Terrain Electric Vehicle). The vehicles were released just last week.

In two studies the acellular tissue engineered vessel (ATEV) provided benefits in terms of patency, limb salvage, and infection resistance ...

or ATEV, for the treatment of vascular trauma. The company said the agency apologized for the delay and has not yet issued a ...

Management will host a webcast and conference call at 8:30 a.m. ET to discuss recent corporate updates from its acellular tissue engineered vessel (ATEV) programs. Title:Humacyt – ATEV ...

In two studies the acellular tissue engineered vessel (ATEV) provided benefits in terms of patency, limb salvage, and infection resistance compared to current synthetic graft treatment benchmarks ...

The publication “Bioengineered Human Arteries for the Repair of Vascular Injuries” describes two clinical studies in which the ATEV demonstrated benefits in terms of patency (blood flow), limb ...

Backing up a bit, Humacyte filed a BLA in December 2023 after its ATEV demonstrated superiority over a synthetic graft benchmark in a single-arm, open-label, unblinded Phase 2/3 trial (V005).

Humacyte, Inc. HUMA announced a delay in the FDA’s review of its Biologic License Application (BLA) for its Acellular Tissue Engineered Vessel (ATEV).The FDA, which had granted a Priority Review ...

In two studies the acellular tissue engineered vessel (ATEV) provided benefits in terms of patency, limb salvage, and infection resistance compared to current synthetic graft treatment benchmarks – – ...